lobbying_activities: 2689595
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2689595 | 58cfb562-72f6-4181-927e-0a8f892e24da | Q3 | SUMMIT PUBLIC AFFAIRS | 401105467 | VANDA PHARMACEUTICALS INC. | 2021 | third_quarter | PHA | Issues affecting the pharmaceutical industry, including the prescription drug approval process. 21st Century Cures Act 2.0 (proposed legislation). | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-10-19T11:31:44.320000-04:00 |